Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F9PE5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,542
Award facts
- Contract value 100% obligated
- $13,541.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerSourceBergen Drug Corp on February 3, 2026, for the supply of Jardiance 25 mg tablets (90-count) with a contract value of $13,541.59. This firm fixed-price delivery order, which extends through February 4, 2026, operates under a non-set-aside, competitively awarded vehicle and represents a task order against AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Cencora's master IDC, valued at up to $999,999,999.00 and running through December 31, 2031, serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this order—functions as a major pharmaceutical distributor and critical vendor within the federal medical procurement supply chain. The company's role under the DLA Troop Support Medical IDC encompasses delivery of a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Jardiance, a diabetes medication, exemplifies the routine pharmaceutical supply operations supporting military treatment facilities and veterans' healthcare programs under this expansive contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F9PE5?
SPE2DR26F9PE5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F9PE5 worth?
The government has obligated $13,542 on SPE2DR26F9PE5.
Is contract SPE2DR26F9PE5 an order under another contract?
Yes. SPE2DR26F9PE5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9PE5 competed?
The extent of competition for SPE2DR26F9PE5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award